Literature DB >> 25117038

[Analysis of the main ethical conflicts in the 2008 declaration of Helsinki and the proposed changes in the new version].

Sofía P Salas, Moisés Russo N.   

Abstract

The Declaration of Helsinki (DoH) of the World Medical Association is the basis of the rules governing research on human beings. The latest version (enacted in Korea, 2008) has been a source of ethical discussions, particularly regarding the use of placebos, the measures to assure the access of study subjects to interventions identified as beneficial once the study has ended, and the need of a better protection of potentially vulnerable groups. These issues led to draft a revised version, that was approved in 2013. In this paper, we present an ethical analysis of the main changes contained in the DoH, including the proposed changes in the new version, referring, when appropriate, to relevant Chilean laws governing research on human subjects. In our opinion, the 2008 DoH contains significant imprecisions on some of these issues, making a new version of the declaration necessary to fully protect subjects participating in biomedical research, as stated by the new version approved in 2013.

Entities:  

Mesh:

Year:  2014        PMID: 25117038     DOI: 10.4067/S0034-98872014000400009

Source DB:  PubMed          Journal:  Rev Med Chil        ISSN: 0034-9887            Impact factor:   0.553


  2 in total

1.  Non-invasive Prenatal Diagnosis of Chromosomal Aneuploidies and Microdeletion Syndrome Using Fetal Nucleated Red Blood Cells Isolated by Nanostructure Microchips.

Authors:  Chun Feng; Zhaobo He; Bo Cai; Jianhong Peng; Jieping Song; Xuechen Yu; Yue Sun; Jing Yuan; Xingzhong Zhao; Yuanzhen Zhang
Journal:  Theranostics       Date:  2018-02-02       Impact factor: 11.556

2.  Foxp3⁺ Treg Cells Are Associated with Pathological Process of Autoimmune Hepatitis by Activating Methylation Modification in Autoimmune Hepatitis Patients.

Authors:  Jiang Chen; Wen Liu; Wenjing Zhu
Journal:  Med Sci Monit       Date:  2019-08-18
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.